Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

Open access
Marder, Karen, Wang, Yuanjia, Alcalay, Roy N., Mejia-Santana, Helen, Tang, Ming-Xin, Lee, Annie, Raymond, Deborah, Mirelman, Anat, Saunders-Pullman, Rachel, Clark, Lorraine, Ozelius, Laurie, Orr-Urtreger, Avi, Giladi, Nir, Bressman, Susan, For the LRRK2 Ashkenazi Jewish Consortium, Alcalay, Roy N., Tang, Ming-X, Santana, Helen Mejia, Roos, Ernest, Orbe-Reilly, Martha, Fahn, Stanley, Cote, Lucien, Waters, Cheryl, Mazzoni, Pietro, Ford, Blair, Louis, Elan, Levy, Oren, Rosado, Llency, Ruiz, Diana, Dorovski, Tsvyatko, Greene, Paul, Clark, Lorraine, Marder, Karen S, Gurevich, Tanya, Shira, Anat Bar, Weisz, Mali Gana, Yasinovsky, Kira, Zalis, Maayan, Thaler, Avner, Balash, Yaacov, Hertzel, Shabtai, Or, Ziv Gan, Kobo, Hila, Hillel, Ariella, Shkedy, Anat, Orr-Urtreger, Avi, Giladi, Nir, Deik, Andres, Barrett, Matthew J ames, Cabassa, Jose, Groves, Mark, Hunt, Ann L., Lubarr, Naomi, San Luciano, Marta, Miravite, Joan, Palmese, Christina, Sachdev, Rivka, Sarva, Harini, Severt, Lawrence, Shanker, Vicki, Swan, Matthew Carrington, Soto-Valencia, Jeannie, Johannes, Brooke, Ortega, Robert, Ozelius, Laurie, Saunders-Pullman, Rachel, Raymond, Deborah, Bressman, Susan · 2015 · Neurology

Abstract

OBJECTIVE: Estimates of the penetrance of LRRK2 G2019S vary widely (24%-100%), reflective of differences in ascertainment, age, sex, ethnic group, and genetic and environmental modifiers. METHODS: The kin-cohort method was used to predict penetrance in 2,270 relatives of 474 Ashkenazi Jewish (AJ) Parkinson disease (PD) probands in the Michael J. Fox LRRK2 AJ Consortium in New York and Tel Aviv, Israel. Patients with PD were genotyped for the LRRK2 G2019S mutation and at least 7 founder GBA mutations. GBA mutation carriers were excluded. A validated family history interview, including age at onset of PD and current age or age at death for each first-degree relative, was administered. Neurologic examination and LRRK2 genotype of relatives were included when available. RESULTS: Risk of PD in relatives predicted to carry an LRRK2 G2019S mutation was 0.26 (95% confidence interval [CI] 0.18-0.36) to age 80 years, and was almost 3-fold higher than in relatives predicted to be noncarriers (hazard ratio [HR] 2.89, 95% CI 1.73-4.55, p < 0.001). The risk among predicted G2019S carrier male relatives (0.22, 95% CI 0.10-0.37) was similar to predicted carrier female relatives (0.29, 95% CI 0.18-0.40; HR male to female: 0.74, 95% CI 0.27-1.63, p = 0.44). In contrast, predicted noncarrier male relatives had a higher risk (0.15, 95% CI 0.11-0.20) than predicted noncarrier female relatives (0.07, 95% CI 0.04-0.10; HR male to female: 2.40, 95% CI 1.50-4.15, p < 0.001). CONCLUSION: Penetrance of LRRK2 G2019S in AJ is only 26% and lower than reported in other ethnic groups. Further study of the genetic and environmental risk factors that influence G2019S penetrance is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000001708

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 161

Metadata

Authors
Marder, K., Wang, Y., Alcalay, R. N., Mejia-Santana, H., Tang, M.-X., Lee, A., Raymond, D., Mirelman, A., Saunders-Pullman, R., Clark, L., Ozelius, L., Orr-Urtreger, A., Giladi, N., Bressman, S., For the LRRK2 Ashkenazi Jewish Consortium, Alcalay, R. N., Tang, M.-X., Santana, H. M., Roos, E., Orbe-Reilly, M., Fahn, S., Cote, L., Waters, C., Mazzoni, P., Ford, B., Louis, E., Levy, O., Rosado, L., Ruiz, D., Dorovski, T., Greene, P., Clark, L., Marder, K. S., Gurevich, T., Shira, A. B., Weisz, M. G., Yasinovsky, K., Zalis, M., Thaler, A., Balash, Y., Hertzel, S., Or, Z. G., Kobo, H., Hillel, A., Shkedy, A., Orr-Urtreger, A., Giladi, N., Deik, A., Barrett, M. J. A., Cabassa, J., Groves, M., Hunt, A. L., Lubarr, N., San Luciano, M., Miravite, J., Palmese, C., Sachdev, R., Sarva, H., Severt, L., Shanker, V., Swan, M. C., Soto-Valencia, J., Johannes, B., Ortega, R., Ozelius, L., Saunders-Pullman, R., Raymond, D., & Bressman, S.
Venue
Neurology
Published
2015-07-07
Volume
85
Issue
1
Pages
89-95
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1941885394
Cited by
161
References
1
FWCI
10.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium. https://app.cochat.ai/papers/10.1212/wnl.0000000000001708
The paper
Marder, K., Wang, Y., Alcalay, R. N., Mejia-Santana, H., Tang, M.-X., Lee, A., Raymond, D., Mirelman, A., Saunders-Pullman, R., Clark, L., Ozelius, L., Orr-Urtreger, A., Giladi, N., Bressman, S., For the LRRK2 Ashkenazi Jewish Consortium, Alcalay, R. N., Tang, M.-X., Santana, H. M., Roos, E., . . . Bressman, S. (2015). Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium. Neurology. https://doi.org/10.1212/wnl.0000000000001708

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.